Zentalis Pharmaceuticals (ZNTL) Q3 2024 Earnings

9AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.24
-0.78
-0.32
0.14

Details

Expected EPS
-0.840849
Actual EPS
-1.24
Surprise EPS
-0.4
Surprise Percent
+47.47%

Description

Zentalis Pharmaceuticals (ZNTL) has reported earnings of -1.24 per share for Q3 2024.

0 Comments

Share your thoughts